GitLife Biotech

📍 Newcastle, United Kingdom🗓 Founded 2023👥 8 employees💰 Last funded Oct 2023
Biotechnology Research🌐 gitlifebiotech.com
Website LinkedIn
GitLife Biotech has launched www.CellRepo.com, the version control system for synthetic biology, alongside a suite of DNA-based biosecurity tools. Our technologies enable reproducibility and proof of ownership, facilitating scale in synthetic biology. To tie the VCS to the engineered asset we must mark the genome of the biological asset itself. To do so we have developed DNA barcodes to an unprecedented level of sophistication: creating biosecurity tools with varying levels of confidentiality and indelibility. Our protocols cover 90% of the strains used in engineering biology and we are developing more all the time. See www.CellRepo.com for more information and to register. We are a Newcastle University spin out, co-founded with the venture builder Cambridge Future Tech Ltd. We maintain laboratories and offices in both Newcastle and Cambridge, UK.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in GitLife Biotech?
GitLife Biotech has 1 investors on record on gritt.io, including 1 early-stage backers.
When did GitLife Biotech last raise funding?
The most recent investment in GitLife Biotech recorded on gritt.io was in October 2023.
When was GitLife Biotech founded?
GitLife Biotech was founded in 2023.
What industry is GitLife Biotech in?
GitLife Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GitLife Biotech based?
GitLife Biotech is headquartered in Newcastle, United Kingdom.